# An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

> **NCT00412932** · PHASE4 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 178 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Olmesartan medoxomil
- **DRUG:** Olmesartan medoxomil/hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00412932
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2009-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412932, "An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00412932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*